Open Access
Feature Article

What's new in weight loss management and surgery?

Open Access
Feature Article

What's new in weight loss management and surgery?

Tamara C Preda, Veronica A Preda, REGINALD V. LORD

Figures

© animated healthcare ltd/spl/diomedia.com
© animated healthcare ltd/spl/diomedia.com
Dr Veronica Preda is a Consultant Endocrinologist at Macquarie University Hospital; and Senior Clinical Lecturer at Macquarie University, Sydney. Dr Tamara Preda is a General Surgeon at Liverpool Public Hospital, St Vincent’s and Prince of Wales Private Hospitals; and Clinical Lecturer in Surgery at the University of Notre Dame, Sydney. Professor Reginald Lord is an upper Gastrointestinal Surgeon at St Vincent’s Public and Private and Macquarie University Hospitals; and Professor and Head of Surgery at the University of Notre Dame, Sydney, NSW. Dr Veronica Preda and Professor Lord are both members of the multidisciplinary Healthy Weight Clinic at MQ Health, Macquarie University Hospital, Sydney, NSW.

 

Advertisement

References

1.     Willett K, Jiang R, Lenart E, Spiegelman D, Willett W. Comparison of bioelectrical impedance and BMI in predicting obesity-related medical conditions. Obesity 2006; 14: 480-490.
2.     Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 2008; 16: 2323-2330.
3.     Williamson E, Walker AJ, Bhaskaran K, et al. OpenSAFELY: factors associated with COVID-19 related hospital death in the linked electronic health records of 17 million adult NHS patients. Preprint at medRxiv doi: doi.org/10.1101/2020.05.06.20092999
4. Jayawardana R, Ranasinghe P, Sheriff MH, Matthews DR, Katulanda P. Waist to height ratio: a better anthropometric marker of diabetes and cardio-metabolic risks in South Asian adults. Diabetes Res Clin Pract 2013;99: 292-299.
5. Stunkard AJ, Sorensen TI, Hanis C, et al. An adoption study of human obesity. N Engl J Med 1986; 314: 193-198.
6. World Health Organization (WHO). Obesity and overweight. Geneva: WHO; 2017. Available online at: www.who.int/mediacentre/factsheets/fs311/en/ (accessed August 2020).
7.     Lobstein T, Jackson-Leach R. Planning for the worst: estimates of obesity and comorbidities in school-age children in 2025. Pediatr Obes 2016; 11: 321-325.
8.     The GBD 2015 Collaborators. Health effects  of overweight and obesity in 195 countries over  25 years. N Engl J Med 2017; 377: 13-27.
9.     Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist 2010; 15: 556-565.
10. National Institutes of Health. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. 2000. Available online at: www.nhlbi.nih.gov/guidelines/obesity/prctgd_c.pdf (accessed August 2020).
11.    Rodger DE, Mc FJ, Price E. The management of obesity. Can Med Assoc J 1950; 63: 265-269.
12. Capehorn MS, Catarig A-M, Furberg JK, et al. Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10). Diabetes Metab 2020; 46: 100-109.
13. Semaglutide for type 2 diabetes. Aust Prescr 2020; 43: 137-139.
14.    Neoh SL, Sumithran P, Haywood CJ, Houlihan CA, Lee FT, Proietto J. Combination phentermine and topiramate for weight maintenance: the first Australian experience. Med J Aust 2014; 201: 224-226.
15.    Australian Government Department of Health. Obesity review; 2011. Canberra: Department of Health; 2011. Available online at: www.health.gov.au/internet/main/publishing.nsf/Content/Obesity_ Review (accessed August 2020).
16.    Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012; 367: 695-704.
17.     Australian Government National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia. Canberra: Commonwealth of Australia; 2013. Available online at: www.nhmrc.gov.au/about-us/publications/clinical-practice-guidelines-management-overweight-and-obesity (accessed August 2020).
18.    Australian Government National Health and Medical Research Council. Australian guide to healthy eating. Canberra: Commonwealth of Australia, 2016. Available online at: www.eatforhealth.gov.au/guidelines/australian-guide-healthy-eating (accessed September 2017).
19.     Australian Institute of Health and Welfare (AIHW). Weight loss surgery in Australia 2014–15: Australian hospital statistics. Cat. no. HSE 186. Canberra: AIHW; 2017. Available online at: www.aihw.gov.au/getmedia/52999476-6016-456e-8dab-693a329720f7/19104.pdf.aspx?inline=true (accessed August 2020).
20.    Ayloo S, Roh Y, Choudhury N. Laparoscopic, hybrid, and totally robotic Roux-en-Y gastric bypass. J Robot Surg 2016; 10: 41-47.
21.    Anthone GJ, Lord RVN, DeMeester TR, Crookes PF. The duodenal switch operation for the treatment of morbid obesity. Ann Surg 2003; 238: 618-628.
22.    Farey JE, Preda TC, Fisher OM, et al. Effect of laparoscopic sleeve gastrectomy on fasting gastrointestinal, pancreatic, and adipose-derived hormones and on non-esterified fatty acids. Obes Surg 2017; 27: 399-407.
23.    Peterli R, Borbely Y, Kern B, et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg 2013; 258: 690-694.
24.    Esteban Varela J, Nguyen NT. Laparoscopic sleeve gastrectomy leads the U.S. utilization of bariatric surgery at academic medical centers. Surg Obes Relat Dis 2015; 11: 987-990.
25.    Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev 2014; (8): CD003641.
26.    van Wageningen B, Berends FJ, Van Ramshorst B, Janssen IF. Revision of failed laparoscopic adjustable gastric banding to Roux-en-Y gastric bypass. Obes Surg 2006; 16: 137-141.
27.    Dumonceau JM, Francois E, Hittelet A, Mehdi AI, Barea M, Deviere J. Single vs repeated treatment with the intragastric balloon: a 5-year weight loss study. Obes Surg 2010; 20: 692-697.
28.    Singh RP, Gans R, Kashyap SR, et al. Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes. Diabetes Care 2015; 38: e32-e33.
29.    Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577-1585.
30.    Ikramuddin S, Billington CJ, Lee WJ, et al.  Roux-en-Y gastric bypass for diabetes  (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol 2015; 3: 413-422.
31.    Arterburn DE, Olsen MK, Smith VA, et al. Association between bariatric surgery and long-term survival. JAMA 2015; 313: 62-70.
32.    Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery.  N Engl J Med 2007; 357: 753-761.
33.    Chakravarty PD, McLaughlin E, Whittaker D, et al. Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials. Surgeon 2012; 10: 172-182.